Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

2024's Top Rulings In Native American Law No Photo Available

Crystal Owens

The U.S. Supreme Court this year has handed down rulings with huge price tags attached — from millions in healthcare reimbursement fun... (more story)

Healthcare Hires: Leech Tishman, Weil, Henry Ford Health No Photo Available

Gianna Ferrarin

Full-service law firm Leech Tishman and healthcare boutique Nelson Hardiman announced plans to combine in early October, while Henry F... (more story)

Free Speech Or Bad Medicine? The Abortion 'Reversal' Battle No Photo Available

Dan McKay

The marketing of abortion pill "reversal" — a treatment doubted by medical groups but touted by anti-abortion advocates — is facing in... (more story)